Ulta Beauty, Inc. carries a market capitalization of 20.56B, placing it among publicly traded companies globally. Its enterprise value stands at 30.72B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 20.56B |
| Enterprise Value | 30.72B |
Ulta Beauty, Inc. currently has 44.17M shares outstanding.
| Shares Outstanding | 44.17M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Ulta Beauty, Inc. trades at a trailing price-to-earnings ratio of 25.17. The price-to-sales ratio is 2.34, and the price-to-book ratio stands at 16.71.
| PE Ratio | 25.17 |
| PS Ratio | 2.34 |
| PB Ratio | 16.71 |
| P/TBV Ratio | 12.23 |
| P/FCF Ratio | 19.39 |
| P/OCF Ratio | 19.32 |
On an enterprise value basis, Ulta Beauty, Inc. trades at an EV/EBITDA multiple of 16.61 and an EV/FCF ratio of 20.40. The EV/Sales ratio of 2.48 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 19.83 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.48 |
| EV / EBITDA | 16.61 |
| EV / EBIT | 19.83 |
| EV / FCF | 20.40 |
Ulta Beauty, Inc. maintains a current ratio of 1.41, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 77.83, indicating elevated leverage, while an interest coverage ratio of 448.60 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.41 |
| Quick Ratio | 0.36 |
| Debt / Equity | 77.83 |
| Debt / EBITDA | 1.18 |
| Interest Coverage | 448.60 |
Ulta Beauty, Inc. posts a return on equity of 71.83 and a return on invested capital of 24.35.
| Return on Equity (ROE) | 71.83 |
| Return on Assets (ROA) | 17.74 |
| Return on Invested Capital (ROIC) | 24.35 |
| Return on Capital Employed (ROCE) | 31.61 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.64 |
Over the trailing twelve months, Ulta Beauty, Inc. has paid 373.87M in income taxes, reflecting an effective tax rate of 24.42.
| Income Tax | 373.87M |
| Effective Tax Rate | 24.42 |
Ulta Beauty, Inc.'s stock has declined approximately -0.62945192% over the past 52 weeks. The 50-day moving average sits at 524.26, while the 200-day moving average is 567.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -0.62945192% |
| 50-Day Moving Average | 524.26 |
| 200-Day Moving Average | 567.00 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Ulta Beauty, Inc. generated 12.39B in revenue and converted that into 1.15B in net income, yielding earnings per share of 25.63. EBITDA reached 1.85B, while operating income came in at 1.55B.
| Revenue | 12.39B |
| Gross Profit | 4.85B |
| Operating Income | 1.55B |
| Pretax Income | 1.53B |
| Net Income | 1.15B |
| EBITDA | 1.85B |
| EBIT | 1.55B |
| Earnings Per Share (EPS) | 25.63 |
Ulta Beauty, Inc. holds 494.24M in cash and equivalents against 2.18B in total debt, resulting in a net debt position of -361.96M. Total book value stands at 1.74B, with working capital of 919.80M providing operational flexibility.
| Cash & Cash Equivalents | 494.24M |
| Total Debt | 2.18B |
| Net Debt | -361.96M |
| Equity (Book Value) | 1.74B |
| Book Value Per Share | 38.74 |
| Working Capital | 919.80M |
Ulta Beauty, Inc. produced 1.50B in operating cash flow over the past twelve months.
| Operating Cash Flow | 1.50B |
| Capital Expenditures | N/A |
| Free Cash Flow | 1.50B |
| FCF Per Share | 33.51 |
Ulta Beauty, Inc. operates with a gross margin of 39.10, reflecting its pricing power and cost economics. The operating margin of 12.50 and net profit margin of 9.31 provide insight into operational efficiency.
| Gross Margin | 39.10 |
| Operating Margin | 12.50 |
| Pretax Margin | 12.36 |
| Profit Margin | 9.31 |
| EBITDA Margin | 14.92 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 2.93 |
| FCF Yield | 5.16 |
Ulta Beauty, Inc. posts an Altman Z-Score of 7.35, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.35 |